Remove Demo Remove Insurance Remove Packaging
article thumbnail

The European Market Access Lag: 2021–2024

Pharmaceutical Technology

For a demo or further information, please contact us here. Our unparalleled team of in-house experts monitor P&R policy developments, outcomes and data analytics around the world every day to give our clients the edge by providing critical early warning signals and insights. Give your business an edge with our leading industry insights.

article thumbnail

Navigating tariffs and diplomacy: the future of India-US pharmaceutical trade

Pharmaceutical Technology

For a demo or further information, please contact us here. Our unparalleled team of in-house experts monitor P&R policy developments, outcomes and data analytics around the world every day to give our clients the edge by providing critical early warning signals and insights. Give your business an edge with our leading industry insights.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Uruguay progresses towards developing its first regulatory agency

Pharmaceutical Technology

For a demo or further information, please contact us here. How will RFK Jr’s American dream for vaccines play out? Our unparalleled team of in-house experts monitors P&R policy developments, outcomes and data analytics around the world every day to give our clients the edge by providing critical early warning signals and insights.

article thumbnail

Trump’s 200% tariff threat could send shockwaves through pharma supply chains

Pharmaceutical Technology

Request a free demo for GlobalData’s Strategic Intelligence here. How will RFK Jr’s American dream for vaccines play out? Eli Lilly will be investing an extra $27bn into US-based sites, with Novartis , Sanofi , and others having made similar moves to onshore manufacturing in the country. Sign up for our daily news round-up!